241
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Glomerular Disturbances in Preeclampsia: Disruption Between Glomerular Endothelium and Podocyte Symbiosis

, , MD, PhD & , MD, PhD
Pages 10-20 | Published online: 12 Jan 2010

REFERENCES

  • Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183(1):S1–S22.
  • Maynard SE, Min JY, Merchan J, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5):649–658.
  • Levine RJ, Maynard SE, Qian C, Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7):672–683.
  • Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007; 18(8):2281–2284.
  • Hladunewich MA, Myers BD, Derby GC, Course of preeclamptic glomerular injury after delivery. Am J Physiol Renal Physiol 2008; 294(3):F614–620.
  • Singh A, Satchell SC, Chris R. Neal, Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007; 18:2885–2893.
  • Garovic VD, Wagner SJ, Petrovic LM, Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant 2007; 22(4):1136–1143.
  • Collino F, Bussolati B, Gerbaudo E, Pre-eclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 2008; 294(5):F1185–94.
  • Henao DE, Arias LF, Mathieson PW, Preeclamptic sera directly induce slit diaphragm protein redistribution and alter podocyte barrier forming capacity. Nephron Experimental Nephrology 2008; 110(3):e73–81.
  • Foster RR, Saleem MA, Mathieson PW, Bates DO, Harper SJ. Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes. Am J Physiol Renal Physiol 2005; 288(1):F48–57.
  • Guan F, Villegas G, Teichman J, Mundel P, Tufro A. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Am J Physiol Renal Physiol 2006; 291(2):F422–428.
  • Eremina V, Jefferson JA, Kowalewska J, VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358(11):1129–1136.
  • Strevens H, Wide-Swensson D, Hansen A, Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2003;, 110(9):831–836.
  • de Swiet M, Lightstone L. Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 2004; 111:191–195.
  • Henao DE, Mathieson PW, Saleem MA, Bueno JC, Cadavid A. A novel renal perspective of preeclampsia: a look from the podocyte. Nephrol Dial Transplant 2007; 22(5):1477.
  • Tryggvason K, Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 2001; 10(4):543–549.
  • Garovic VD, Wagner SJ, Turner ST, Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007; 196(4):320, e321–327.
  • Karumanchi SA, Lindheimer MD. Preeclampsia and the kidney: footprints in the urine. Am J Obstet Gynecol 2007; 196(4):287–288.
  • Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308(5728):1592–1594.
  • Sugimoto H, Hamano Y, Charytan D, Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003; 278(15):12605–12608.
  • Eremina V, Sood M, Haigh J, Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111(5):707–716.
  • Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amore PA. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006; 168(2):639–648.
  • Foster RR, Hole R, Anderson K, Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 2003; 284(6):F1263–1273.
  • Feng D, Nagy JA, Brekken RA, Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 2000; 48(4):545–556.
  • Harper SJ, Xing CY, Whittle C, Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo. Clin Sci (Lond) 2001; 101(4):439–446.
  • Fuh G, Garcia KC, de Vos AM. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J Biol Chem 2000; 275(35):26690–26695.
  • Li Z, Zhang Y, Ying Ma J, Recombinant Vascular Endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 2007; 50:686–692.
  • Quaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences. Development 2008; 135(4):609–620.
  • Hirschberg R, Wang S, Mitu GM. Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 2008; 331(2):485–493.
  • Satchell SC, Tasman CH, Singh A, Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 2006; 69(9):1633–1640.
  • Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008; 88(2):451–487.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.